Age 0 3 0 3 B-age
: 3 4 3 4 O
≥18 5 8 5 8 O
- 9 10 9 10 O
≤ 11 12 11 12 O
40 13 15 13 15 B-upper_bound
years 16 21 16 21 I-upper_bound
of 22 24 22 24 O
age 25 28 25 28 B-age

BMI 0 3 29 32 B-bmi
< 4 5 33 34 O
25 5 7 34 36 B-upper_bound
kg 8 10 37 39 I-upper_bound
/ 10 11 39 40 I-upper_bound
m2 11 13 40 42 I-upper_bound
( 14 15 43 44 O
Lean 15 19 44 48 O
control 20 27 49 56 O
) 27 28 56 57 O
and 29 32 58 61 O
≥30 33 36 62 65 O
kg 37 39 66 68 I-lower_bound
/ 39 40 68 69 I-lower_bound
m2 40 42 69 71 I-lower_bound
( 43 44 72 73 O
Obese 44 49 73 78 O
subjects 50 58 79 87 O
) 58 59 87 88 O

Blood 0 5 89 94 B-clinical_variable
pressure 6 14 95 103 I-clinical_variable
systolic 15 23 104 112 I-clinical_variable
≤125 24 28 113 117 O
and 29 32 118 121 O
diastolic 33 42 122 131 B-clinical_variable
≤85 43 46 132 135 O
mmHg 47 51 136 140 I-upper_bound
( 52 53 141 142 I-upper_bound
Lean 53 57 142 146 I-upper_bound
control 58 65 147 154 I-upper_bound
) 65 66 154 155 I-upper_bound
and 67 70 156 159 O
< 71 72 160 161 O
140 72 75 161 164 B-upper_bound
and 76 79 165 168 O
diastolic 80 89 169 178 O
< 90 91 179 180 O
90 91 93 180 182 B-upper_bound
mmHg 94 98 183 187 I-upper_bound
( 99 100 188 189 O
Obese 100 105 189 194 O
subjects 106 114 195 203 O
) 114 115 203 204 O

Females 0 7 205 212 B-gender
: 7 8 212 213 O
Self 9 13 214 218 O
- 13 14 218 219 O
reported 14 22 219 227 O
pregnancy 23 32 228 237 B-pregnancy
and/or 33 39 238 244 O
breastfeeding 40 53 245 258 O
, 53 54 258 259 O
diagnosed 55 64 260 269 O
with 65 69 270 274 O
polycystic 70 80 275 285 B-chronic_disease
ovarian 81 88 286 293 I-chronic_disease
syndrome 89 97 294 302 I-chronic_disease
, 97 98 302 303 O
or 99 101 304 306 O
without 102 109 307 314 O
regular 110 117 315 322 O
menses 118 124 323 329 O

Must 0 4 330 334 O
be 5 7 335 337 O
studied 8 15 338 345 O
in 16 18 346 348 O
the 19 22 349 352 O
early 23 28 353 358 O
follicular 29 39 359 369 B-clinical_variable
phase 40 45 370 375 I-clinical_variable
( 46 47 376 377 O
day 47 50 377 380 B-lower_bound
1 51 52 381 382 I-lower_bound
- 52 53 382 383 O
5 53 54 383 384 B-upper_bound
) 54 55 384 385 O
of 56 58 386 388 O
their 59 64 389 394 O
menstrual 65 74 395 404 B-clinical_variable
cycle 75 80 405 410 I-clinical_variable
or 81 83 411 413 O
the 84 87 414 417 O
low 88 91 418 421 O
hormone 92 99 422 429 O
phase 100 105 430 435 O
of 106 108 436 438 O
oral 109 113 439 443 O
contraceptive 114 127 444 457 O
use 128 131 458 461 O

Negative 0 8 462 470 B-pregnancy
pregnancy 9 18 471 480 I-pregnancy
test 19 23 481 485 O

Participation 0 13 486 499 O
in 14 16 500 502 O
vigorous 17 25 503 511 O
aerobic 26 33 512 519 O
exercise 34 42 520 528 O
> 43 44 529 530 O
90 44 46 530 532 B-lower_bound
minutes 47 54 533 540 I-lower_bound
per 55 58 541 544 I-lower_bound
week 59 63 545 549 I-lower_bound

Regularly 0 9 550 559 O
( 10 11 560 561 O
≥5 11 13 561 563 O
days 14 18 564 568 I-lower_bound
/ 18 19 568 569 I-lower_bound
week 19 23 569 573 I-lower_bound
) 23 24 573 574 O
take 25 29 575 579 O
acetylsalicylic 30 45 580 595 B-treatment
acid 46 50 596 600 I-treatment

Self 0 4 601 605 O
- 4 5 605 606 O
reported 5 13 606 614 O
current 14 21 615 622 O
diagnosis 22 31 623 632 O
of 32 34 633 635 O
exhibiting 35 45 636 646 O
obstructive 46 57 647 658 B-chronic_disease
sleep 58 63 659 664 I-chronic_disease
apnea 64 69 665 670 I-chronic_disease

Self 0 4 671 675 O
- 4 5 675 676 O
reported 5 13 676 684 O
history 14 21 685 692 O
of 22 24 693 695 O
hematologic 25 36 696 707 B-chronic_disease
disease 37 44 708 715 I-chronic_disease

Self 0 4 716 720 O
- 4 5 720 721 O
reported 5 13 721 729 O
history 14 21 730 737 O
of 22 24 738 740 O
hepatic 25 32 741 748 B-chronic_disease
disease 33 40 749 756 I-chronic_disease

Self 0 4 757 761 O
- 4 5 761 762 O
reported 5 13 762 770 O
history 14 21 771 778 O
of 22 24 779 781 O
peripheral 25 35 782 792 B-chronic_disease
vascular 36 44 793 801 I-chronic_disease
disease 45 52 802 809 I-chronic_disease

Self 0 4 810 814 O
- 4 5 814 815 O
reported 5 13 815 823 O
history 14 21 824 831 O
of 22 24 832 834 O
renal 25 30 835 840 B-chronic_disease
disease 31 38 841 848 I-chronic_disease

Sensitivity 0 11 849 860 O
to 12 14 861 863 O
lidocaine 15 24 864 873 B-treatment

Specific 0 8 874 882 O
to 9 11 883 885 O
obese 12 17 886 891 O
subjects 18 26 892 900 O
only 27 31 901 905 O
( 32 33 906 907 O
to 33 35 907 909 O
exclude 36 43 910 917 O
obese 44 49 918 923 O
subjects 50 58 924 932 O
with 59 63 933 937 O
metabolic 64 73 938 947 B-chronic_disease
syndrome 74 82 948 956 I-chronic_disease
) 82 83 956 957 O

Taking 0 6 958 964 O
cardiovascular 7 21 965 979 B-treatment
medications 22 33 980 991 I-treatment
( 34 35 992 993 O
anti 35 39 993 997 B-treatment
- 39 40 997 998 I-treatment
hypertensives 40 53 998 1011 I-treatment
, 53 54 1011 1012 O
statins 55 62 1013 1020 B-treatment
, 62 63 1020 1021 O
platelet 64 72 1022 1030 B-treatment
inhibitors 73 83 1031 1041 I-treatment
, 83 84 1041 1042 O
etc 85 88 1043 1046 O
. 88 89 1046 1047 O
) 89 90 1047 1048 O
or 91 93 1049 1051 O
metabolic 94 103 1052 1061 B-treatment
medications 104 115 1062 1073 I-treatment
( 116 117 1074 1075 O
insulin 117 124 1075 1082 B-treatment
- 124 125 1082 1083 I-treatment
sensitizing 125 136 1083 1094 I-treatment
) 136 137 1094 1095 O

non 0 3 1096 1099 B-treatment
- 3 4 1099 1100 I-treatment
steroidal 4 13 1100 1109 I-treatment
anti 14 18 1110 1114 I-treatment
- 18 19 1114 1115 I-treatment
inflammatory 19 31 1115 1127 I-treatment
drugs 32 37 1128 1133 I-treatment
( 38 39 1134 1135 I-treatment
NSAIDs 39 45 1135 1141 I-treatment
) 45 46 1141 1142 I-treatment

